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Abstract
Background: There has been considerable concern expressed about the outcomes achieved in Independent Sector
Treatment Centres (ISTCs) introduced in England since 2003. Our aim was to compare the case-mix and patients'
reported outcomes of surgery in ISTCs and in NHS providers.
Methods: Prospective cohort study of 769 patients treated in six ISTCs and 1895 treated in 20 NHS providers (acute
hospitals and treatment centres) in England during 2006–07. Participants underwent one of three day surgery procedures
(inguinal hernia repair, varicose vein surgery, cataract extraction) or hip or knee replacement. Change in patient-
reported health status and health related quality of life (measured using a disease-specific and a generic (EQ-5D)
instrument) was assessed either 3-months (day surgery) or 6-months (hip/knee) after surgery. In addition patient-
reported post-operative complications and an overall assessment of success of surgery were collected. Outcome
measures were adjusted (using multivariable regression) for patient characteristics (disease severity, duration of
symptoms, age, sex, socioeconomic status, general health, previous similar surgery, comorbidity).
Results: Post-operative response rates varied by procedure (73%–88%) and were similar for those treated in ISTCs and
NHS facilities. Patients treated in ISTCs were healthier, were less likely to have any comorbidity and, for those
undergoing cataract surgery or joint replacement, their primary condition was less severe. Those undergoing hernia
repair or joint replacement were less likely to have had similar surgery before.
When adjustment was made for pre-operative characteristics, patients undergoing cataract surgery or hip replacement
in ISTCs achieved a slightly greater improvement in functional status and quality of life than those treated in NHS facilities,
while the opposite was true of patients undergoing hernia repair. No significant differences were found for the two other
procedures. Patients treated in ISTCs were less likely to report post-operative problems than those treated in NHS
facilities for cataract surgery (Adjusted Odds Ratio 0.35; 95% CI 0.17–0.70), hernia repair (0.42; 0.28–0.63) and knee
replacement (0.44; 0.28–0.69). Most patients described the result of their operation as excellent, very good or good,
regardless of where they were treated.
Conclusion: The case-mix of patients treated in ISTCs differs from that in NHS providers, in line with the intention of
the contracts. Caution is needed in interpreting the observation that patients treated in ISTCs reported slightly better
outcomes as very few ISTCs participated, case-mix adjustment might have been insufficient, and patients' reports might
have been biased as they were more likely to be satisfied with the way they were treated.
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Background
In 2002 the Department of Health committed to increas-
ing the permanent capacity for elective surgery (and diag-
nostic services) in England by establishing more
Diagnosis and Treatment Centres [1]. The aim was not
only to reduce waiting times for routine procedures but
also to expand choice and to increase productivity
through innovative models of care. Unlike the ten existing
NHS centres (including one run jointly with a private pro-
vider), expansion was partly to be achieved by encourag-
ing private companies to establish facilities employing
staff not currently working for the NHS, thus creating
additional capacity in England. The first of these Inde-
pendent Sector Treatment Centres (ISTCs), focusing on
low risk ophthalmic, orthopaedic and day surgery,
opened in 2003. By October 2004, six centres had been
established and had treated 16 000 patients [2].
Following some concerns about the policy of introducing
ISTCs [3,4], the House of Commons Health Committee
undertook a review in spring 2006. In addition to receiv-
ing evidence about poor value for money, adverse impact
on surgical training, loss of continuity of care, lack of ade-
quate clinical governance, and jeopardising the viability
of existing NHS providers, clinicians reported seeing seri-
ous complications in patients who had been treated in
ISTCs [5-8]. However, as some of them acknowledged,
meaningful comparisons with NHS providers could not
be made both because of the poor quality of the data col-
lected by ISTCs [9] and the historical lack of routine data
on outcome collected by the NHS. When the Health Com-
mittee reported in July 2006, it agreed "that there was no
hard, quantifiable evidence to prove that standards in
ISTCs differed from those in the NHS" and "recom-
mended that comparable and standardised data be col-
lected" [10]. This was welcomed by clinicians [11], some
of whom had been advocating such an approach [12].
Meanwhile, in April 2006 the Secretary of State for Health
pre-empted the Health Committee's report by announc-
ing the establishment of "a wide-ranging clinical audit" to
be carried out by the Healthcare Commission [13]. How-
ever, inevitably, when it appeared in July 2007, it too con-
firmed the lack of available routine data with which to
assess outcomes [14].
Fortunately, in 2004 the Department of Health's Eco-
nomic and Operational Research Division foresaw the
need for meaningful comparisons of the performance of
providers in the emerging world of choice. They commis-
sioned a project to review international evidence on
patient-reported outcome measures for five elective surgi-
cal procedures and to establish a demonstration project
with three objectives: to test the feasibility of data collec-
tion in ISTCs and NHS providers; to establish how best to
analyse the data; and to explore how best to present inter-
provider comparisons. As only two ISTCs agreed to take
part, the DH Commercial Directorate subsequently
funded data collection from an additional four centres.
These combined data provide the first opportunity to
address some of the concerns of clinicians, the Health
Committee, independent sector providers and policy-
makers.
In this paper our objectives are to compare the case-mix of
ISTCs and NHS providers (acute hospitals and treatment
centres) and patient-reported outcomes in terms of
change in health status/quality of life, post-operative
complications and overall result of surgery. Comparisons
of individual centres will appear elsewhere.
Methods
Twenty-six providers (13 NHS hospitals, 7 NHS treatment
centres, 6 ISTCs) participated. Ethical approval was
granted by the Wales MREC. Consecutive patients (apart
from those with cognitive impairment, poor sight, literacy
or language comprehension problems) were eligible.
Recruitment, which lasted for up to six months between
January 2006 and April 2007, was carried out by nursing
or administrative staff who explained what the study
involved (completion of a pre and post-operative ques-
tionnaire) and obtained written consent. This took place
either in a pre-operative assessment clinic or on admis-
sion for surgery. The pre-operative questionnaire that
included: age, sex and postcode (to determine an Index of
Multiple Deprivation [15] – higher scores indicate more
deprived); duration of symptoms; history of previous sim-
ilar surgery; general health status (five categories); co-
morbidities [16]; and the EQ-5D, a generic measure of
health-related quality of life [17]. In addition, a disease-
specific measure of functional status/health-related qual-
ity of life was included: the VF14 for cataract surgery [18];
the Aberdeen Varicose Vein Questionnaire – AVVQ [19];
the Oxford Hip Score – OHS [20]; and the Oxford Knee
Score – OKS [21]. As no specific measure for hernia repair
has been validated, the Physical Component Summary
(PCS) of the SF-36 was used [22]. Higher scores represent
better outcomes for the EQ-5D, the PCS and the VF14. The
reverse is true for the OHS, OKS and the AVVQ.
Post-operative questionnaires were mailed three (for her-
nia, cataract and varicose vein surgery) or six months
(joint replacement) after surgery to patients' homes from
the Royal College of Surgeons of England. Non-respond-
ers were sent a reminder letter and replacement question-
naire five weeks after the original mailing. The
questionnaires contained: general health status; EQ-5D; a
relevant disease-specific instrument; a question relating to
complications – "Did you experience any of the following
problems after your operation?" (allergy or reaction to
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drug, and urinary, bleeding or wound problems) [23];
and a global evaluation – "How would you describe the
results of your operation?".
Summary statistics of pre-operative characteristics are
reported for each operation group by treatment sector.
Post-operative response bias was investigated by using t-
tests to compare the pre-operative disease-specific instru-
ment scores of patients who did and did not respond. The
primary outcomes were the post-operative generic and
disease-specific PROM scores, adjusted for pre-operative
patient characteristics (age, sex, socioeconomic status,
comorbidities, duration of symptoms, previous similar
surgery, general health status, EQ-5D). Secondary out-
comes were the risk-adjusted proportions of patients
reporting any complications and rating their operation as
excellent, very good, or good.
Risk-adjustment of outcomes was conducted using linear
regression (logistic regression for post-operative compli-
cation incidence and overall operation success) with pre-
operative PROM scores and other patient characteristics
(age, sex, general health status, duration of symptoms,
number of comorbidities, Index of Multiple Deprivation,
previous similar surgery) being potential risk factors.
To account for possible clustering of patient outcomes
within hospitals, we used robust standard errors. All P val-
ues are 2-sided and P values lower than 0.05 were consid-
ered a statistically significant result. Stata software was
used for all calculations [24].
Results
Recruitment and response rates
During the recruitment period, 769 patients were
recruited in ISTCs and 1895 in NHS providers. Data on
the number of eligible patients were not obtained in 2
ISTCs and 3 NHS centres. However, in the other 4 ISTCs
and 17 NHS centres, the proportion of eligible patients
recruited in the ISTCs was higher: cataract surgery 72% v
66%; hernia repair 62% v 50%; varicose vein surgery 84%
v 66%; hip replacement 98% v 54%; and knee replace-
ment 100% v 56%.
There was little difference in post-operative response rate
between patients treated in ISTCs and NHS facilities: cata-
ract surgery 84% v 86%; hernia repair 70% v 77%; vari-
cose vein surgery 68% v 74%; hip replacement 77% v
88%; and knee replacement 85% v 88%. In both treat-
ment sectors and across all five procedures a comparison
of the pre-operative disease-specific PROM scores of those
who did and did not return a post-operative questionnaire
revealed no statistically significant differences.
Case-mix
Generally, patients undergoing day surgery in ISTCs were
healthier and had a less severe primary condition than
those in NHS facilities (Table 1): cataract patients were
less likely to be in poor/fair health or to suffer any comor-
bidity, and their visual function was better; hernia
patients were younger, had less comorbidity, had a shorter
duration of symptoms, and were less likely to have under-
gone hernia repair before; and varicose vein patients were
younger and were less likely to be in poor/fair health.
Similar differences were observed for those undergoing
joint replacement (Table 2): patients treated in ISTCs were
less likely to be in poor/fair health or to suffer any comor-
bidity, their primary condition was less severe and, for
hips, they were less likely to have undergone previous
similar surgery.
Table 1: Pre-operative characteristics of day surgery patients
Patient characteristic Cataract surgery Hernia repair Varicose vein surgery
NHS (N = 590) ISTC (N = 276) NHS (N = 422) ISTC (N = 69) NHS (N = 269) ISTC (N = 53)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 73.7 (10.6) 74.6 (10.0) 53.4 (18.0) 48.7 (14.1) 46.6 (13.5) 42.2 (16.5)
Duration symptoms (years) 2.8 (3.7) 2.6 (3.0) 2.8 (5.6) 1.6 (1.9) 13.6 (11.5) 12.8 (8.6)
Deprivation score 20.3 (14.1) 16.5 (9.3) 18.6 (15.5) 33.2 (18.9) 20.1 (14.8) 33.4 (21.7)
EQ-5D score 0.80 (0.24) 0.84 (0.22) 0.78 (0.18) 0.76 (0.19) 0.76 (0.19) 0.78 (0.16)
Disease-specific score 81.8 (17.9) 84.7 (15.9) 47.2 (9.2) 46.6 (9.2) 16.9 (8.3) 15.8 (8.4)
N (%) N (%) N (%) N (%) N (%) N (%)
Female 340 (57.7) 156 (56.5) 47 (11.1) 3 (4.3) 178 (66.2) 33 (62.3)
Any comorbidity 465 (78.8) 197 (71.4) 207 (49.1) 27 (39.1) 160 (59.5) 25 (57.2)
Previous similar surgery 202 (34.5) 90 (32.7) 84 (20.2) 9 (13.4) 86 (32.7) 15 (28.9)
Poor or fair health 131 (22.3) 45 (16.4) 34 (8.1) 4 (5.8) 27 (10.2) 3 (5.7)
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Patient-reported outcomes
For all procedures, except hernia repair, post-operative
PROM scores in ISTC patients indicated better outcomes
than those treated by NHS providers (Table 3). However,
when adjustment was made for pre-operative characteris-
tics statistically significant differences persisted for cata-
ract surgery and hip replacement, both favouring patients
treated at ISTCs: cataract surgery patients achieved a sig-
nificantly better outcome on the VF14 (2.6 points on a
100-point scale, p = 0.005) and the EQ-5D (0.03 points
on a 0 to 1 scale, p = 0.01); hip replacement patients on
the OHS (2.4 points on a 70-point scale, p = 0.03) and the
EQ-5D (0.06 points, p = 0.03).
Fewer patients treated in ISTCs reported a post-operative
complication than patients treated in NHS facilities, even
after adjusting for pre-operative risk factors (Table 4).
These differences were statistically significant for cataract
surgery, hernia repair and knee replacement. Considera-
tion of each of the four types of complication separately
revealed that all four were reported less often by patients
undergoing these procedures in ISTCs (Table 5).
Most patients described the result of their operation as a
success (i.e. excellent, very good or good) both in ISTCs
and NHS facilities: cataract surgery 97% v 91%; hernia
surgery 98% v 94%; varicose vein surgery 71% v 86%; hip
replacement 98% v 92%; and knee replacement 85% v
87%. Following risk adjustment patients undergoing var-
icose vein surgery in an ISTC were less likely to describe
their operation as a success (Adjusted Odds Ratio 0.38;
95% CI 0.15–0.90; p = 0.03) while those undergoing her-
nia surgery were more likely to declare it a success
(Adjusted Odds Ratio 3.2; 95% CI 1.2–8.1; p = 0.02).
Table 2: Pre-operative characteristics of joint replacement patients
Patient characteristic Hip replacement Knee replacement
NHS (N = 291) ISTC (N = 184) NHS (N = 323) ISTC (N = 187)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 66.2 (14.6) 66.8 (14.1) 66.2 (16.5) 66.7 (12.2)
Duration symptoms (years) 3.9 (5.4) 3.7 (3.9) 8.1 (10.1) 8.6 (9.3)
Deprivation score 22.4 (16.8) 20.3 (13.3) 25.2 (17.4) 19.0 (12.6)
EQ-5D score 0.31 (0.31) 0.35 (0.32) 0.36 (0.32) 0.45 (0.30)
Disease-specific score 44.0 (7.7) 42.1 (8.4) 42.3 (7.5) 39.8 (8.0)
N (%) N (%) N (%) N (%)
Female 157 (54.1) 108 (58.7) 167 (52.0) 96 (51.6)
Any comorbidity 251 (86.2) 148 (80.4) 280 (86.7) 151 (80.7)
Previous similar surgery 79 (27.3) 34 (18.6) 168 (53.3) 78 (42.6)
Poor or fair health 62 (21.5) 27 (14.9) 68 (21.7) 21 (11.5)
Table 3: Unadjusted and adjusted post-operative PROM scores by operation
PROMs NHS ISTC Adjusted difference* 95% CI P-value
Mean (SD) Mean (SD)
EQ-5D
Cataract 0.77 (0.28) 0.84 (0.23) 0.03 0.009 to 0.06 0.01
Hernia 0.85 (0.21) 0.84 (0.22) -0.02 -0.05 to 0.002 0.07
Varicose vein 0.87 (0.20) 0.89 (0.19) 0.005 -0.03 to 0.04 0.8
Hip 0.72 (0.26) 0.82 (0.20) 0.06 0.005 to 0.11 0.03
Knee 0.70 (0.26) 0.76 (0.22) 0.03 -0.02 to 0.08 0.2
Disease-specific
Cataract (VF14) 92.3 (15.2) 96.2 (7.8) 2.6 0.97 to 4.2 0.005
Hernia (PCS) 50.1 (9.6) 51.8 (10.5) 1.2 -0.52 to 2.9 0.2
Varicose vein (AVVQ) 10.3 (9.0) 8.6 (7.9) 1.3 -3.1 to 0.49 0.5
Hip (OHS) 23.9 (9.9) 20.5 (7.6) 2.4 -4.4 to -0.36 0.03
Knee (OKS) 27.0 (9.3) 24.2 (8.8) 0.86 -3.7 to 2.0 0.5
*positive adjusted differences indicate better post-operative scores for ISTC patients
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Discussion
Findings
In line with their contracts, ISTCs tend to treat healthier
patients with less severe primary conditions. Having
adjusted for such differences in case-mix, patients
reported similar improvements in function and health-
related quality of life following hernia repair, varicose
vein surgery and knee replacement in ISTCs and NHS pro-
viders. Improvements following cataract surgery and hip
replacement were slightly greater in patients treated in
ISTCs. There was also a lower incidence of complications
reported by ISTC patients undergoing cataract, hernia and
knee surgery.
Limitations
There are four reasons for caution in interpreting these
comparisons between ISTCs and NHS providers. First,
although a high proportion of eligible patients were
recruited in the ISTCs, the small number of ISTCs that par-
ticipated limits the generalisability of the results. While
patients undergoing joint replacement were recruited
from four ISTCs, only one ISTC was involved for hernia
and varicose vein surgery. Second, a lower proportion of
patients were recruited in NHS centres than in ISTCs. It is
possible that this difference could have introduced a bias.
Third, the risk adjustment models had only poor predic-
tive power (area under ROC curve about 0.6). It is proba-
ble that the addition of clinician-reported data would
Table 4: Proportion of patients reporting at least one complication by operation
Surgery type NHS ISTC Adjusted odds ratio 95% CI P-value
N (%) N (%)
Cataract surgery 58 (11.5) 9 (3.9) 0.32 0.14 to 0.70 0.004
Hernia repair 79 (24.4) 8 (16.7) 0.46 0.32 to 0.66 <0.001
Varicose vein 83 (41.5) 13 (36.1) 0.75 0.42 to 1.3 0.3
Hip replacement 87 (33.9) 41 (29.1) 0.87 0.52 to 1.5 0.6
Knee replacement 112 (39.6) 39 (24.5) 0.43 0.27 to 0.69 <0.001
Table 5: Proportion of patients reporting complications by operation
Operation NHS ISTC Adjusted odds ratio 95% CI P-value
N (%) N (%)
Cataract
Bleeding 17 (3.4) 5 (2.2) 0.74 0.37 to 1.5 0.4
Wound infection 18 (3.6) 2 (0.9) 0.13 0.02 to 1.0 0.05
Urinary problems 12 (2.4) 1 (0.4) 0.26 0.03 to 2.5 0.2
Adverse drug reaction 19 (3.8) 4 (1.7) 0.53 0.19 to 1.5 0.2
Hernia repair
Bleeding 19 (5.9) 2 (4.2) 0.80 0.35 to 1.8 0.6
Wound infection 35 (10.8) 4 (8.3) 0.58 0.33 to 1.0 0.06
Urinary problems 20 (6.2) 3 (6.2) 0.82 0.43 to 1.5 0.5
Adverse drug reaction 21 (6.5) 1 (2.1) 0.16 0.10 to 0.27 <0.001
Varicose vein surgery
Bleeding 51 (25.5) 8 (22.2) 0.71 0.30 to 1.7 0.4
Wound infection 50 (25.0) 9 (25.0) 1.2 0.74 to 2.0 0.4
Urinary problems 7 (3.5) 1 (2.8) 1.2 0.46 to 3.3 0.7
Adverse drug reaction 10 (5.0) 0 (0) 1.0 0.94 to 1.0 0.7
Hip replacment
Bleeding 27 (10.5) 10 (7.1) 0.88 0.47 to 1.7 0.7
Wound infection 27 (10.5) 15 (10.6) 1.2 0.58 to 2.6 0.6
Urinary problems 33 (12.8) 12 (8.5) 0.67 0.35 to 1.3 0.2
Adverse drug reaction 29 (11.3) 15 (10.6) 0.84 0.39 to 1.8 0.6
Knee replacement
Bleeding 25 (8.8) 7 (4.4) 0.45 0.14 to 1.4 0.2
Wound infection 42 (14.8) 14 (8.8) 0.50 0.28 to 0.90 0.02
Urinary problems 42 (14.8) 13 (8.2) 0.51 0.29 to 0.88 0.02
Adverse drug reaction 39 (13.8) 16 (10.1) 0.65 0.43 to 0.97 0.04
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improve the predictive power of our models. Fourth, there
may have been some reporting bias. If ISTC patients were
more satisfied with their experience, as has been reported
[14], they may have been less critical of their outcome.
While not undermining comparisons between types of
provider, the validity and reliability of the absolute values
reported could be challenged. Although the instruments
used were the best available in psychometric terms, the
validity of at least one (the VF14) has been challenged by
clinicians [25], though it is unclear how justified such crit-
icism is. Another concern is the validity of patients' report-
ing of complications: patients may wrongly attribute a
problem to the operation and/or they may interpret nor-
mal post-operative recovery, such as some wound discom-
fort, to be a 'complication'. Despite these concerns, there
is evidence that the question has sufficient construct valid-
ity for comparative purposes: reports of bleeding and
wound problems were much higher following varicose
vein surgery (around 25%) than after cataract surgery
(around 3%) and the incidence of urinary problems was
higher after joint replacement (12%) than after hernia
repair (6%) or varicose vein or cataract surgery (2–3%).
Implications
These, the first quantitative data to cast light on the effec-
tiveness of surgery in ISTCs, suggest there is no widespread
problem with poor quality care. Indeed, the lower inci-
dence of patient-reported complications following treat-
ment in an ISTC is reassuring. These findings do not refute
previous reports of individual instances of serious lapses
in the quality care in some ISTCs, they simply suggest that
such failures are uncommon. Inevitably, there is no infor-
mation yet available as to the long-term outcomes.
Although these findings provide some systematic evi-
dence about the effectiveness and safety of ISTCs, the con-
clusions have to be tentative given the relatively small
sample of providers and patients. A larger sample would
enable the generalisability of these findings to be tested,
provide greater statistical power, and allow more robust
risk-adjustment models to take into account case-mix dif-
ferences. In addition, the inclusion of clinician-reported
outcomes would allow an assessment of the effect of sur-
gery on impairments (such as visual acuity and extent of
joint movement) and enable a clinical view of the inci-
dence of complications to be obtained. An audit of hip
and knee replacements in all ISTCs and representative
sample of NHS providers is due to start soon.
Conclusion
The case-mix of patients treated in ISTCs differs from that
in NHS providers, in line with the intention of the con-
tracts. Caution is needed in interpreting the observation
that patients treated in ISTCs reported slightly better out-
comes as very few ISTCs participated, case-mix adjustment
might have been insufficient, and patients' reports might
have been biased as they were more likely to be satisfied
with the way they were treated.
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